Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Maintenance in c-kit Positive AML
NCT00509093Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Oct 2008
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in acute myeloid leukemia (AML), sponsored by Case Comprehensive Cancer Center. Started Oct 2008; status: completed.
02
Drugs
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00509093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00509093.